This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DECORAH, Iowa — It was livestock check-in day at the Winneshiek County Fair, and the dairy barn was consumed with a kind of pre-prom anxiety. A cow named Daiquiri was lumbering back from the milking parlor, adjusting to a new schedule that would have her “mammary system” bulging for showtime. Kennedy was getting a fresh shave, tufts of udder-fuzz drifting to the floor, revealing her resplendent venation.
Facing increasing doubts that the U.S. can control the outbreak of avian influenza among dairy cattle, federal officials reiterated on Tuesday that they believe the country can still eliminate the H5N1 virus from dairy cows, even as it continues to spread to new herds. “All the signs that we have are, with good biosecurity, with good farmer participation, we will be able to eliminate this,” Eric Deeble, the acting senior adviser for the H5N1 response at the U.S.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Centers for Disease Control and Prevention just released a trove of data on Americans with disabilities that found that more than a quarter of U.S. adults have a disability — over 70 million people, a bump from prior years. This slice of the population was also much more likely to report long Covid symptoms such as chronic fatigue and brain fog.
Michael Bloomberg’s donation of $1 billion to Johns Hopkins University to support medical education goes beyond similar gifts to other medical schools. The Bloomberg gift provides support to students in Hopkins’ schools of nursing and public health, not just in its medical school. As health professionals and educators, we are thrilled to see philanthropists supporting the future of medical training in the U.S.
CHICAGO – The FDA’s top food regulator contended Tuesday that the agency could not have done much more to prevent the recent contamination of children’s applesauce with lead. The official, Food and Drug Administration Deputy Commissioner Jim Jones, argued that if companies like the producer of the lead-laced cinnamon in the applesauce “are hell bent about breaking the rules, they’re usually going to get away with it for a little while before they’re stop
Community pharmacies in south-east London have launched what is believed to be England’s only nationally-funded inhaler recycling pilot. NHS England (NHSE) has funded the scheme, which aims to reduce greenhouse gases from metered dose inhalers. Patients will be encouraged to return their used or expired inhalers to one of 20 participating community pharmacies.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A cancer care navigation startup has raised $95 million from prominent tech investors to help payers and providers spend less on cancer patients while improving their health — including by doling out incentive payments to providers and keeping a cut of insurers’ savings. Thyme Care’s Series C round included new investor Concord Health Partners, and repeat investors such as Town Hall Ventures, Andreessen Horowitz, Foresite Capital and CVS Health Ventures, the company tol
Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep throat and instead of being prescribed an antibiotic you are told it isn’t urgent and you can wait to treat it. A solution is within reach: It starts with recognizing the power of integrating hepatitis C treatment with addiction care.
The well-funded startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from Takeda Pharmaceuticals, has raised $260 million for a Series B round. The financing was led by Ascenta Capital, a new VC firm that has quietly begun leading biotech investment deals while raising its first fund. Ascenta was started last year by Moderna’s former finance chief Lorence Kim and former head of strategy Evan Rachlin.
UnitedHealth Group’s CEO said Tuesday that his team was “over-optimistic” about the pace at which providers would reconnect with Change Healthcare after the claims-processing unit sustained a sweeping cyberattack. Andrew Witty’s comments came toward the end of the company’s second-quarter earnings call, in which UnitedHealth disclosed it now expects to shoulder an up to $1.9 billion post-tax hit from the mid-February cyberattack, higher than the $1.6 billion es
Pfizer Inc. (NYSE: PFE) announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Most pregnant people are in regular touch with their maternity care providers over the course of nine months, with ever-more-frequent visits, tests, and scans as their due date nears. For many patients, this is the first time in their lives they’ve been in such close, routine contact with the health system. Then, after delivering the child, this attention all but vanishes.
Lupin today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g , to market a generic equivalent of Sutab Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories. “Lupin is the exclusive first-to-file for this product and may be eligible for 180-day exclusivity.
Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the official mascots are scampering about and enjoying summertime fun. As for the rest of us, well, we can only dream. But our to-do list will keep us busy, including chats with some interesting folks. Hopefully, you can relate. Either way, it is time to get cracking.
CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The weather here in Chicago has been super volatile. We’ve had thunderstorms the last few days, and last night I heard for the first time a tornado warning. Truly an ominous start to the week!
If you’re a long-time reader of our blogs, you might be familiar with the phrase “ is the name of the game,” and rightfully so. The pharmacy industry consists.
Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […] Source
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content